Your browser doesn't support javascript.
loading
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD.
Jaramillo, Sonia; Le Cornet, Lucian; Kratzmann, Markus; Krisam, Johannes; Görner, Martin; Hänel, Mathias; Röllig, Christoph; Wass, Maxi; Scholl, Sebastian; Ringhoffer, Mark; Reichart, Alexander; Steffen, Björn; Kayser, Sabine; Mikesch, Jan-Henrik; Schaefer-Eckart, Kerstin; Schubert, Jörg; Geer, Thomas; Martin, Sonja; Kieser, Meinhard; Sauer, Tim; Kriegsmann, Katharina; Hundemer, Michael; Serve, Hubert; Bornhäuser, Martin; Müller-Tidow, Carsten; Schlenk, Richard F.
Afiliação
  • Jaramillo S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. Sonia.jaramillosegura@med.uni-heidelberg.de.
  • Le Cornet L; NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Kratzmann M; NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Krisam J; Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
  • Görner M; Department of Hematology, Oncology and Palliative Medicine, Community Hospital Bielefeld, Bielefeld, Germany.
  • Hänel M; Department of Medicine III, Hospital Chemnitz gGmbH, Chemnitz, Germany.
  • Röllig C; Department of Medicine and Polyclinic I, TU Dresden University Hospital, Dresden, Germany.
  • Wass M; Department of Medicine IV, Halle (Saale) University Hospital, Halle, Germany.
  • Scholl S; Department of Medicine II, Jena University Hospital, Jena, Germany.
  • Ringhoffer M; Department of Medicine, III, Hospital Karlsruhe, Karlsruhe, Germany.
  • Reichart A; Department of Hematology, Oncology and Palliative Medicine, Hospital Winnenden, Winnenden, Germany.
  • Steffen B; Department of Medicine II, Frankfurt University Hospital, Frankfurt, Germany.
  • Kayser S; Department of Medicine I - Hematology and Cell Therapy, Leipzig University Hospital, Leipzig, Germany.
  • Mikesch JH; Department of Medicine A, Münster University Hospital, Münster, Germany.
  • Schaefer-Eckart K; Department of Inner Medicine V, North Hospital Nürnberg, Nürnberg, Germany.
  • Schubert J; Department of Inner Medicine II, Elbland Hospital Riesa, Riesa, Germany.
  • Geer T; Department of Medicine II, Diaconal Hospital Schwäbisch-Hall, Schwäbisch Hall, Germany.
  • Martin S; Department of Hematology, Oncology and Palliative Medicine, Robert-Bosch Hospital, Stuttgart, Germany.
  • Kieser M; Department of Hematology, Oncology and Palliative Medicine, Robert-Bosch Hospital, Stuttgart, Germany.
  • Sauer T; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Kriegsmann K; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Hundemer M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Serve H; Department of Medicine II, Frankfurt University Hospital, Frankfurt, Germany.
  • Bornhäuser M; Department of Medicine and Polyclinic I, TU Dresden University Hospital, Dresden, Germany.
  • Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Schlenk RF; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Trials ; 24(1): 591, 2023 Sep 15.
Article em En | MEDLINE | ID: mdl-37715270
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Mitoxantrona Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Mitoxantrona Idioma: En Ano de publicação: 2023 Tipo de documento: Article